The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival.

Nucleic Acids Res 2014 Mar 24;42(5):3218-27. Epub 2013 Dec 24.

Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy, Laboratories of Neuroembryology and of Cellular and Molecular Neurobiology, Fondazione Santa Lucia IRCCS, 00143 Rome, Italy, Department of Psychology, II University of Naples, Caserta, Italy, Department of Functional Genomics and Cancer, Institut de Genetique et de Biologie Moleculaire et Cellulaire, F-67400, INSERM U964, F-67400 Illkirch, France and Department of Health Sciences, University of Rome Foro Italico, Rome, Italy.

NEK2 is a serine/threonine kinase that promotes centrosome splitting and ensures correct chromosome segregation during the G2/M phase of the cell cycle, through phosphorylation of specific substrates. Aberrant expression and activity of NEK2 in cancer cells lead to dysregulation of the centrosome cycle and aneuploidy. Thus, a tight regulation of NEK2 function is needed during cell cycle progression. In this study, we found that NEK2 localizes in the nucleus of cancer cells derived from several tissues. In particular, NEK2 co-localizes in splicing speckles with SRSF1 and SRSF2. Moreover, NEK2 interacts with several splicing factors and phosphorylates some of them, including the oncogenic SRSF1 protein. Overexpression of NEK2 induces phosphorylation of endogenous SR proteins and affects the splicing activity of SRSF1 toward reporter minigenes and endogenous targets, independently of SRPK1. Conversely, knockdown of NEK2, like that of SRSF1, induces expression of pro-apoptotic variants from SRSF1-target genes and sensitizes cells to apoptosis. Our results identify NEK2 as a novel splicing factor kinase and suggest that part of its oncogenic activity may be ascribed to its ability to modulate alternative splicing, a key step in gene expression regulation that is frequently altered in cancer cells.

Download full-text PDF

Source
https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/
Publisher Site
http://dx.doi.org/10.1093/nar/gkt1307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950702PMC
March 2014

Publication Analysis

Top Keywords

cancer cells
12
nek2
10
splicing factor
8
cell cycle
8
novel splicing
8
factor kinase
8
nek2 novel
8
splicing
6
oncogenic srsf1
4
srsf1 protein
4
including oncogenic
4
phosphorylates including
4
splicing factors
4
factors phosphorylates
4
protein overexpression
4
srsf1 reporter
4
nek2 induces
4
splicing activity
4
proteins splicing
4
endogenous proteins
4

Similar Publications